Wang, Shusen <br/><br/>
Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens.  [electronic resource] 

 -  Medical oncology (Northwood, London, England)  Jun 2012 
 - 547-53 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1559-131X 
<br/><br/><label>Standard No.: </label>10.1007/s12032-011-9964-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Anthracyclines--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Bridged-Ring Compounds--therapeutic use<br/>Cyclophosphamide--therapeutic use<br/>Female<br/>Fluorouracil--therapeutic use<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Neoplasm Staging<br/>Prognosis<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Retrospective Studies<br/>Survival Rate<br/>Taxoids--therapeutic use<br/>Young Adult